The above chart presents the market trend analysis for pharmanex huzhou health from 2023 to 2024.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2024, the company has completed 2 transactions, with a transaction quantity of 245 and a transaction weight of 6983.
YearTransactionsQuantityWeight
2023000
202422456983
Bill of lading data
<
1/15
>
Trade date
2024/08/03
B/L No.
zimusnh7622055
Suppliers
pharmanex huzhou health
Buyers
nse products inc
3nse products inc
netherlandsbuyer,they trade on 2024-08-03
31.64%
>
Products
Total 10
ProductsTransactionsPerDetail
green tea extract 250%>
reishi extract powder 250%>
ginseng extract 250%>
cod 250%>
gin 125%>
+View All
Hscode rank
Total 7
HSCode NameTransactionsPerDetail
HS 130219250%>
Trading Area
Total 1
AreaTransactionsPerDetail
united states183100%>
Port statistics
Total 1
Port NameTransactionsPerDetail
shanghai13975.96%>
pharmanex huzhou health is china Supplier,
and primarily engages in the import and export business of products such as green tea extract,reishi extract powder,ginseng extract.
According to the 52wmb.com global trade database, as of 2024-08-03, the company has completed 183 international trades,
with its main trading regions covering united states etc.
The core products include HS130219 etc,
often transported via shanghai etc,
and its main trading partners are nu skin international,niki johnson nse products inc.,nse products inc.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on pharmanex huzhou health is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.